Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys

Share |

Disease Mongering
When Is the Line Crossed?

Disease mongering is a term that was coined by the late journalist Lynn Payer to describe what she saw as the confluence of interests by some doctors, drug companies, patient advocacy groups and media in exaggerating the severity of illness and the ability of drugs to "cure" them. Some critics suggest that even pharma-sponsored disease awareness campaigns are forms of disease mongering. Pharma Marketing News recently hosted a live podcast interview of two experts in this area and this article summarizes this lively point-counterpoint discussion.

Topics and questions covered include:

  • Defining Disease Mongering
  • Is It a Legitimate Issue?
  • HCP Co-conspirators
  • Patient Advocate Co-conspirators
  • RLS Foundation's Ties to GSK
  • Does DTC Foster "Disease Mongering?"
  • Disease Awareness or Disease Mongering?
  • Effect on Industry Reputation

Read this article now. It's FREE...

Download PDF file

PMN63-01
Issue: Vol. 6, No. 3: March 2007
Word Count: 3377

Find other articles in related Topic Areas:

Vol 6, #3 Contents







Contact Information
Editor
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.